Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
1,139
-
Total 13F shares, excl. options
-
211,034,733
-
Shares change
-
-9,127,692
-
Total reported value, excl. options
-
$18,456,804,032
-
Value change
-
-$793,360,418
-
Put/Call ratio
-
29%
-
Number of buys
-
400
-
Number of sells
-
-545
-
Price
-
$87.47
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q4 2021
1,239 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q4 2021.
NOVARTIS AG - Ordinary Shares (NVS) has 1,139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 211,034,733 shares
of 2,181,288,547 outstanding shares and own 9.67% of the company stock.
Largest 10 shareholders include Dodge & Cox (28,249,540 shares), PRIMECAP MANAGEMENT CO/CA/ (18,165,590 shares), LOOMIS SAYLES & CO L P (17,893,566 shares), Fisher Asset Management, LLC (10,384,666 shares), FRANKLIN RESOURCES INC (9,140,807 shares), BANK OF AMERICA CORP /DE/ (7,788,298 shares), Boston Partners (4,677,403 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4,205,694 shares), UBS Group AG (4,178,900 shares), and WELLINGTON MANAGEMENT GROUP LLP (4,096,452 shares).
This table shows the top 1139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.